Humana Inc. (NYSE:HUM) Receives Average Rating of “Hold” from Brokerages

Shares of Humana Inc. (NYSE:HUM) have earned a consensus recommendation of “Hold” from the twenty-eight brokerages that are presently covering the stock, MarketBeat Ratings reports. Four equities research analysts have rated the stock with a sell rating, fifteen have assigned a hold rating, eight have issued a buy rating and one has given a strong buy rating to the company. The average 1-year price objective among brokerages that have issued a report on the stock in the last year is $291.3478.

HUM has been the topic of several recent research reports. Deutsche Bank Aktiengesellschaft downgraded shares of Humana from a “buy” rating to a “hold” rating in a research report on Wednesday, May 20th. Cantor Fitzgerald reiterated a “neutral” rating on shares of Humana in a research report on Thursday. Zacks Research upgraded shares of Humana from a “strong sell” rating to a “hold” rating in a research report on Wednesday, May 13th. Needham & Company LLC initiated coverage on shares of Humana in a research report on Wednesday, May 20th. They set a “buy” rating on the stock. Finally, Royal Bank Of Canada reiterated a “sector perform” rating on shares of Humana in a research report on Monday, June 1st.

Humana Stock Up 2.9%

NYSE:HUM opened at $379.42 on Friday. The firm’s 50 day simple moving average is $267.90 and its 200 day simple moving average is $237.20. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.77 and a quick ratio of 1.77. Humana has a one year low of $163.11 and a one year high of $379.50. The company has a market cap of $45.55 billion, a PE ratio of 40.58, a P/E/G ratio of 2.16 and a beta of 0.76.

Humana (NYSE:HUM) last posted its earnings results on Wednesday, April 29th. The insurance provider reported $10.31 EPS for the quarter, topping the consensus estimate of $9.97 by $0.34. Humana had a net margin of 0.82% and a return on equity of 10.45%. The business had revenue of $39.65 billion for the quarter, compared to the consensus estimate of $39.37 billion. During the same period last year, the company earned $11.58 EPS. The firm’s revenue was up 23.5% compared to the same quarter last year. Humana has set its FY 2026 guidance at 9.000- EPS. On average, research analysts anticipate that Humana will post 9.04 earnings per share for the current year.

Humana Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Friday, June 26th will be given a $0.885 dividend. The ex-dividend date is Friday, June 26th. This represents a $3.54 dividend on an annualized basis and a dividend yield of 0.9%. Humana’s payout ratio is 37.86%.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently modified their holdings of HUM. Capital International Investors lifted its position in shares of Humana by 113.9% in the 4th quarter. Capital International Investors now owns 5,818,008 shares of the insurance provider’s stock worth $1,490,239,000 after purchasing an additional 3,097,571 shares during the period. Norges Bank acquired a new position in shares of Humana in the 4th quarter worth approximately $456,632,000. Pzena Investment Management LLC lifted its position in shares of Humana by 34.3% in the 1st quarter. Pzena Investment Management LLC now owns 5,470,982 shares of the insurance provider’s stock worth $948,614,000 after purchasing an additional 1,398,774 shares during the period. Wellington Management Group LLP lifted its position in shares of Humana by 4,481.7% in the 4th quarter. Wellington Management Group LLP now owns 1,196,502 shares of the insurance provider’s stock worth $306,460,000 after purchasing an additional 1,170,387 shares during the period. Finally, Franklin Resources Inc. lifted its position in shares of Humana by 914.5% in the 4th quarter. Franklin Resources Inc. now owns 1,255,665 shares of the insurance provider’s stock worth $321,613,000 after purchasing an additional 1,131,893 shares during the period. Institutional investors and hedge funds own 92.38% of the company’s stock.

Humana Company Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.